MIRM earnings
Mirum Pharmaceuticals (MIRM) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
MIRM earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 5, 2026 | -1.06 | -0.74 | -42.75% | $176.24M |
| Q1 2026 | May 6, 2026 | -13.43 | -0.40 | -3257.50% | $159.88M |
| Q4 2025 | Feb 25, 2026 | -0.11 | 0.02 | -650.00% | $148.93M |
| Q3 2025 | Nov 4, 2025 | 0.05 | -0.10 | 150.00% | $133.01M |
| Q2 2025 | Aug 6, 2025 | -0.12 | -0.31 | 61.29% | $127.78M |
| Q1 2025 | May 7, 2025 | -0.30 | -0.39 | 23.08% | $111.58M |
| Q4 2024 | Feb 26, 2025 | -0.49 | -0.27 | -81.48% | $99.41M |
| Q3 2024 | Nov 12, 2024 | -0.30 | -0.45 | 33.33% | $90.38M |
| Q2 2024 | Aug 7, 2024 | -0.52 | -0.48 | -8.33% | $77.88M |
| Q1 2024 | May 8, 2024 | -0.54 | -0.40 | -35.00% | $69.22M |
| Q4 2023 | Feb 28, 2024 | -0.66 | -0.34 | -94.12% | $69.55M |
| Q3 2023 | Nov 2, 2023 | -0.57 | -0.64 | 10.94% | $47.73M |
| Aug 3, 2023 | -1.94 | -0.81 | -139.51% | – | |
| May 4, 2023 | -0.80 | -0.96 | 16.67% | – | |
| Mar 8, 2023 | -0.99 | -0.98 | -1.02% | – | |
| Nov 9, 2022 | -1.02 | -1.05 | 2.86% | – | |
| Aug 4, 2022 | -0.84 | -1.05 | 20.00% | – | |
| May 5, 2022 | -1.17 | -1.39 | 15.83% | – | |
| Mar 9, 2022 | 1.88 | 0.30 | 519.85% | – | |
| Nov 15, 2021 | -1.55 | -1.63 | 4.91% | – |
- MIRM reports next on Nov 3, 2026, with EPS of -0.52 expected.
- MIRM beat EPS estimates in 13 of its last 29 reports.
Updated 2026-11-03 00:58 UTC